Clinical Trials Browser

Phase 2 × Melanoma × Administration, Cutaneous × Clear all

NCT03850691 2024-01-17

Radiation and Combination Immunotherapy for Melanoma

Phase 2 Completed

4 enrolled 11 charts

Melanoma